Immix Biopharma logo

Immix Biopharma Share Price Today

(NASDAQ: IMMX)

Immix Biopharma share price is $1.67 & ₹145.24 as on 6 Mar 2025, 2.30 'hrs' IST

$1.67

0.04

(2.45%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Immix Biopharma share price in Dollar and Rupees. Guide to invest in Immix Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immix Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Immix Biopharma share price movements

  • Today's Low: $1.65
    Today's High: $1.69

    Day's Volatility :2.37%

  • 52 Weeks Low: $1.26
    52 Weeks High: $3.64

    52 Weeks Volatility :65.38%

Immix Biopharma (IMMX) Returns

PeriodImmix Biopharma IncIndex (Russel 2000)
3 Months
-35.32%
0.0%
6 Months
-22.38%
0.0%
1 Year
-51.78%
0.0%
3 Years
-13.3%
-11.6%

Immix Biopharma (IMMX) Key Statistics

in dollars & INR

Previous Close
$1.63
Open
$1.63
Today's High
$1.69
Today's Low
$1.65
Market Capitalization
$44.8M
Today's Volume
$12.4K
52 Week High
$3.64
52 Week Low
$1.26
Revenue TTM
$0.0
EBITDA
$-23.0M
Earnings Per Share (EPS)
$-0.84
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-118.5%

How to invest in Immix Biopharma Stock (IMMX) from India?

It is very easy for Indian residents to invest directly in Immix Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immix Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immix Biopharma or IMMX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immix Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immix Biopharma shares which would translate to 0.521 fractional shares of Immix Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immix Biopharma, in just a few clicks!

Returns in Immix Biopharma (IMMX) for Indian investors in Rupees

The Immix Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immix Biopharma investment value today

Current value as on today

₹54,371

Returns

₹45,629

(-45.63%)

Returns from Immix Biopharma Stock

₹50,592 (-50.59%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Immix Biopharma (IMMX)

71%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Immix Biopharma Stock from India on INDmoney has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Immix Biopharma

  • Bleichroeder LP

    3.09%

  • Cable Car Capital LLC

    2.89%

  • Vanguard Group Inc

    2.54%

  • Geode Capital Management, LLC

    0.55%

  • Morgan Stanley - Brokerage Accounts

    0.33%

  • State Street Corp

    0.16%

Analyst Recommendation on Immix Biopharma

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Immix Biopharma(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Immix Biopharma Stock (IMMX)

What analysts predicted

Upside of 319.16%

Target:

$7.00

Current:

$1.67

Insights on Immix Biopharma Stock (Ticker Symbol: IMMX)

  • Price Movement

    In the last 3 months, IMMX stock has moved down by -35.3%
  • IMMX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 113.1%
  • IMMX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 70.4%

Immix Biopharma Technicals Summary

Sell

Neutral

Buy

Immix Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immix Biopharma (IMMX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Immix Biopharma Inc logo
-17.26%
-22.38%
-51.78%
-13.3%
-55.59%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Immix Biopharma Inc logo
NA
NA
NA
-0.79
-1.18
-0.61
NA
0.64
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Immix Biopharma Inc logo
Buy
$44.8M
-55.59%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Immix Biopharma

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Organization
Immix Biopharma
Employees
14
CEO
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Industry
Miscellaneous

Management People of Immix Biopharma

NameTitle
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Co-Founder, CEO & Chairman
Mr. Gabriel Morris B.A.
CFO & Director
Dr. Graham Ross FFPM, M.D.
Chief Medical Officer & Head of Clinical Development
Mr. Sean Senn J.D., M.B.A., M.Sc., MBA, MSc
Co-Founder
Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.
Scientific Co-Founder
Mr. Nandan Oza B.S.
Head of Chemistry, Manufacturing & Control
Dr. David Marks MBBS, Ph.D.
Chief Medical Officer of Cell Therapy
Mr. Gerhard Bauer
Head of Cell Therapy Manufacturing

Important FAQs about investing in IMMX Stock from India :

What is Immix Biopharma share price today?

Immix Biopharma share price today stands at $1.67, Open: $1.63 ; Previous Close: $1.63 ; High: $1.69 ; Low: $1.65 ; 52 Week High: $3.64 ; 52 Week Low: $1.26.

The stock opens at $1.63, after a previous close of $1.63. The stock reached a daily high of $1.69 and a low of $1.65, with a 52-week high of $3.64 and a 52-week low of $1.26.

Can Indians buy Immix Biopharma shares?

Yes, Indians can invest in the Immix Biopharma (IMMX) from India.

With INDmoney, you can buy Immix Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immix Biopharma at zero transaction cost.

How can I buy Immix Biopharma shares from India?

It is very easy to buy Immix Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immix Biopharma (IMMX) be purchased?

Yes, you can buy fractional shares of Immix Biopharma with INDmoney app.

What are the documents required to start investing in Immix Biopharma stocks?

To start investing in Immix Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Immix Biopharma Stock (IMMX)?

Today’s highest price of Immix Biopharma (IMMX) is $1.69.

Today’s lowest price of Immix Biopharma (IMMX) is $1.65.

What is today's market capitalisation of Immix Biopharma?

Today's market capitalisation of Immix Biopharma IMMX is 44.8M

What is the 52 Week High and Low Range of Immix Biopharma Stock (IMMX)?

  • 52 Week High

    $3.64

  • 52 Week Low

    $1.26

What are the historical returns of Immix Biopharma (IMMX)?

  • 1 Month Returns

    -17.26%

  • 3 Months Returns

    -22.38%

  • 1 Year Returns

    -51.78%

  • 5 Years Returns

    -55.59%

Who is the Chief Executive Officer (CEO) of Immix Biopharma ?

Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D. is the current Chief Executive Officer (CEO) of Immix Biopharma.